2019
DOI: 10.1093/annonc/mdz239.041
|View full text |Cite
|
Sign up to set email alerts
|

Radiomic features as a non-invasive biomarker to predict response to immunotherapy in recurrent or metastatic urothelial carcinoma

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles